Rxivist logo

Author: James G. Kublin

  • Most recently observed institution: Fred Hutchinson Cancer Research Center

Rankings

  • All-time downloads: 35,708 (rank: 7,545 )
  • Categories:
    • infectious diseases: 34,887 (rank: 2,147 )

Downloads per author, site-wide

Preprints

Immune Correlates Analysis of the mRNA-1273 COVID-19 Vaccine Efficacy Trial

infectious diseases more details view paper
  • Downloaded 31,424 times
  • Download rankings, all-time:
    • Site-wide: 335
    • In infectious diseases: 123
  • Year to date:
    • Site-wide: 1,108
  • Since beginning of last month:
    • Site-wide: 4,412

Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials

infectious diseases more details view paper
  • Downloaded 2,356 times
  • Download rankings, all-time:
    • Site-wide: 10,168
    • In infectious diseases: 1,581
  • Year to date:
    • Site-wide: 25,311
  • Since beginning of last month:
    • Site-wide: 61,761

Immune Correlates Analysis of the PREVENT-19 COVID-19 Vaccine Efficacy Clinical Trial

infectious diseases more details view paper
  • Downloaded 925 times
  • Download rankings, all-time:
    • Site-wide: 43,353
    • In infectious diseases: 4,293
  • Year to date:
    • Site-wide: 3,906
  • Since beginning of last month:
    • Site-wide: 3,536

Immune Correlates Analysis of a Single Ad26.COV2.S Dose in the ENSEMBLE COVID-19 Vaccine Efficacy Clinical Trial

infectious diseases more details view paper
  • Downloaded 925 times
  • Download rankings, all-time:
    • Site-wide: 43,352
    • In infectious diseases: 3,798
  • Year to date:
    • Site-wide: 3,911
  • Since beginning of last month:
    • Site-wide: 8,417

High-risk microbial signatures are associated with severe parasitemia in controlled Plasmodium infections of both humans and rhesus macaques

microbiology more details view paper
  • Downloaded 78 times
  • Download rankings, all-time:
    • Site-wide: 204,434
    • In microbiology: None
  • Year to date:
    • Site-wide: 118,543
  • Since beginning of last month:
    • Site-wide: None

PanLingua

News